Maryland Heights, MO, May 17, 2017 --(PR.com
)-- Protein engineering is the design of new enzymes or proteins with new or desirable functions. It is the conception and production of unnatural polypeptides, often through modification of amino acid sequences that are found in nature. Synthetic protein structures and functions can now be designed entirely on a computer or produced through directed evolution in the laboratory. In rational protein design, the scientist uses detailed knowledge of the structure and function of the protein to make desired changes. In general, this has the advantage of being inexpensive and technically easy, since site-directed mutagenesis techniques are well-developed. In directed evolution, random mutagenesis is applied to a protein, and a selection regime is used to pick out variants that have the desired qualities, where further rounds of mutation and selection are then applied. This method mimics natural evolution and, in general, may produce superior results to rational design.
Visit Protein Engineering Market by Technology (Rational Product Design, Directed Evolution), and End User (Academic Research Institutes, Biotechnology Companies, Contract Research Organizations, Pharmaceutical Enterprises) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/protein-engineering-market/
The global protein (antibody) engineering market segmentation is based on technology (rational product design, directed evolution), and end user (academic research institutes, biotechnology and pharmaceutical companies, contract research organizations).
The global protein (antibody) engineering market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global protein (antibody) engineering market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global protein (antibody) market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global protein (antibody) engineering market and included in this report are BioXcell, Covalab, Emerald Bio, Fusion Antibodies, GenTarget, Inc., IBL International, ImaginAb, Precision Antibody, and ProSci, Inc.
1.1. Rational Product Design
1.2. Directed Evolution
2. End User
2.1. Academic Research Institutes
2.2. Biotechnology and Pharmaceutical Companies
2.3. Contract Research Organizations
3. Company Profiles
3.3. Emerald Bio
3.4. Fusion Antibodies
3.5. GenTarget, Inc.
3.6. IBL International
3.8. Precision Antibody
3.9. ProSci, Inc.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043